B-cell Activating Factor Receptor Expression is Associated with Germinal Center B-cell Maintenance

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2019 Feb 21

PMID 30783477

Citations 10

Authors

Francisco Josue Carrillo-Ballesteros

Edith Oregon-Romero

Ramon Antonio Franco-Topete

Luis Humberto Govea-Camacho

Alvaro Cruz

Jose Francisco Munoz-Valle

Felipe Jesus Bustos-Rodriguez

Ana Laura Pereira-Suarez

Claudia Azucena Palafox-Sanchez

Affiliations

Soon will be listed here.

Abstract

B-cell activating factor (BAFF) is a major cytokine that regulates B-cell survival, maturation and differentiation through its binding with its receptors: BAFF receptor (BAFF-R), transmembrane activator and cyclophilin ligand interactor (TACI) and B-cell maturation antigen (BCMA). These receptors have been demonstrated to be involved in tertiary lymphoid structure formation; however, their role in germinal centers (GCs) has remained elusive. The aim of the present study was to determine the expression profiles of BAFF and its receptors in secondary lymphoid tissues. Tonsils resected due to chronic tonsillitis were used as lymphoid tissues. To confirm the presence of GCs identified based on their typical structure, CD21 antibody staining was employed. The expression of BAFF, BAFF-R, TACI and BCMA was assessed by immunohistochemistry. BAFF was highly expressed in all regions of the follicle, but the highest BAFF expression was detected in the mantle zone (MZ). A high expression of BAFF-R was observed on lymphocytes in the MZ in comparison with the other regions (~80%; P<0.05), which was co-localizated with BAFF (r=0.646; P<0.001), in the MZ. TACI and BCMA exhibited similar expression among the different zones of the GCs, and co-localization with BAFF was observed inside the follicle, mainly in the dark zone. The present results indicate that BAFF is implicated in the maintenance of GCs. BAFF-R overexpression in the MZ, co-localizated with BAFF, suggests that these proteins constitute the principal pathway for the maintenance of the naïve B-cell population. Furthermore, TACI and BCMA have a role in the GC, where processes of B-cell selection, proliferation and differentiation into immunoglobulin-secreting plasma cells occur.

Citing Articles

Forging the Future: B Cell Activating Factor's Impact on Nephrotic Syndrome.

Kardani A, Fitri L, Samsu N, Subandiyah K Malays J Med Sci. 2025; 31(6):57-64.

PMID: 39830109 PMC: 11740809. DOI: 10.21315/mjms2024.31.6.5.

CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases.

Vukovic J, Abazovic D, Vucetic D, Medenica S Front Med (Lausanne). 2024; 11:1447147.

PMID: 39450112 PMC: 11500465. DOI: 10.3389/fmed.2024.1447147.

Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options.

Mititelu A, Onisai M, Rosca A, Vladareanu A Int J Mol Sci. 2024; 25(4).

PMID: 38396839 PMC: 10889445. DOI: 10.3390/ijms25042163.

Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues.

Giovannini D, Belbezier A, Baillet A, Bouillet L, Kawano M, Dumestre-Perard C Front Immunol. 2023; 14:1111366.

PMID: 36895558 PMC: 9989216. DOI: 10.3389/fimmu.2023.1111366.

Dual Role of B Cells in Multiple Sclerosis.

Kumar G, Axtell R Int J Mol Sci. 2023; 24(3).

PMID: 36768658 PMC: 9916779. DOI: 10.3390/ijms24032336.

References

Brauninger A, Yang W, Wacker H, Rajewsky K, Kuppers R, Hansmann M . B-cell development in progressively transformed germinal centers: similarities and differences compared with classical germinal centers and lymphocyte-predominant Hodgkin disease. Blood. 2001; 97(3):714-9. DOI: 10.1182/blood.v97.3.714. View

von Bulow G, Van Deursen J, Bram R . Regulation of the T-independent humoral response by TACI. Immunity. 2001; 14(5):573-82. DOI: 10.1016/s1074-7613(01)00130-3. View

Yan M, Wang H, Chan B, Roose-Girma M, Erickson S, Baker T . Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol. 2001; 2(7):638-43. DOI: 10.1038/89790. View

MacLennan I, Vinuesa C . Dendritic cells, BAFF, and APRIL: innate players in adaptive antibody responses. Immunity. 2002; 17(3):235-8. DOI: 10.1016/s1074-7613(02)00398-9. View

Craxton A, Magaletti D, Ryan E, Clark E . Macrophage- and dendritic cell--dependent regulation of human B-cell proliferation requires the TNF family ligand BAFF. Blood. 2003; 101(11):4464-71. DOI: 10.1182/blood-2002-10-3123. View

Scapini P, Nardelli B, Nadali G, Calzetti F, Pizzolo G, Montecucco C . G-CSF-stimulated neutrophils are a prominent source of functional BLyS. J Exp Med. 2003; 197(3):297-302. PMC: 2193843. DOI: 10.1084/jem.20021343. View

Vora K, Wang L, Rao S, Liu Z, Majeau G, Cutler A . Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function. J Immunol. 2003; 171(2):547-51. DOI: 10.4049/jimmunol.171.2.547. View

Novak A, Darce J, Arendt B, Harder B, Henderson K, Kindsvogel W . Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood. 2003; 103(2):689-94. DOI: 10.1182/blood-2003-06-2043. View

Rahman Z, Rao S, Kalled S, Manser T . Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice. J Exp Med. 2003; 198(8):1157-69. PMC: 2194236. DOI: 10.1084/jem.20030495. View

10.

Hase H, Kanno Y, Kojima M, Hasegawa K, Sakurai D, Kojima H . BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood. 2003; 103(6):2257-65. DOI: 10.1182/blood-2003-08-2694. View

11.

OConnor B, Raman V, Erickson L, Cook W, Weaver L, Ahonen C . BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 2004; 199(1):91-8. PMC: 1887725. DOI: 10.1084/jem.20031330. View

12.

Thien M, Phan T, Gardam S, Amesbury M, Basten A, Mackay F . Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004; 20(6):785-98. DOI: 10.1016/j.immuni.2004.05.010. View

13.

Ng L, Sutherland A, Newton R, Qian F, Cachero T, Scott M . B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol. 2004; 173(2):807-17. DOI: 10.4049/jimmunol.173.2.807. View

14.

Novak A, Grote D, Stenson M, Ziesmer S, Witzig T, Habermann T . Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome. Blood. 2004; 104(8):2247-53. DOI: 10.1182/blood-2004-02-0762. View

15.

Ohata J, Zvaifler N, Nishio M, Boyle D, Kalled S, Carson D . Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines. J Immunol. 2005; 174(2):864-70. DOI: 10.4049/jimmunol.174.2.864. View

16.

Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, Monoranu C . BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med. 2005; 201(2):195-200. PMC: 2212784. DOI: 10.1084/jem.20041674. View

17.

Ogden C, Pound J, Batth B, Owens S, Johannessen I, Wood K . Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma. J Immunol. 2005; 174(5):3015-23. DOI: 10.4049/jimmunol.174.5.3015. View

18.

Schneider P . The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol. 2005; 17(3):282-9. DOI: 10.1016/j.coi.2005.04.005. View

19.

Zhang X, Park C, Yoon S, Li L, Hsu Y, Ambrose C . BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol. 2005; 17(6):779-88. DOI: 10.1093/intimm/dxh259. View

20.

Pers J, Daridon C, Devauchelle V, Jousse S, Saraux A, Jamin C . BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci. 2005; 1050:34-9. DOI: 10.1196/annals.1313.004. View